Literature DB >> 20713497

The effects of antidepressant step therapy protocols on pharmaceutical and medical utilization and expenditures.

Tami L Mark1, Teresa M Gibson, Kimberly McGuigan, Bong Chul Chu.   

Abstract

OBJECTIVE: This study examined the effects of step therapy for antidepressants on prescription drug and other medical utilization and spending. Step therapy is a type of pharmaceutical benefit design that requires that patients try certain specified medications (typically generic medications) prior to using alternative, more expensive medications within the same medication class. Step therapy is not the same as generic substitution.
METHOD: Using the 2003-2006 Thomson Reuters MarketScan claims databases, antidepressant users enrolled in employer plans that implemented antidepressant step therapy were compared with antidepressant users enrolled in employer plans that had not implemented step therapy. Multivariate generalized estimating equation models were used to analyze the relationship between step therapy for antidepressants and 1) pharmacy and medical utilization and 2) spending.
RESULTS: Antidepressant days supplied and medication costs decreased after step therapy was implemented, relative to the comparison group. However, overall and mental health-specific inpatient and emergency room utilization and costs increased.
CONCLUSIONS: Step therapy may have the unintended effect of reducing overall antidepressant use and increasing medical use and costs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713497     DOI: 10.1176/appi.ajp.2010.09060877

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  6 in total

1.  Medicare Part D plan generosity and medication use among dual-eligible nursing home residents.

Authors:  Haiden A Huskamp; David G Stevenson; A James O'Malley; Stacie B Dusetzina; Susan L Mitchell; Barbara J Zarowitz; Michael E Chernew; Joseph P Newhouse
Journal:  Med Care       Date:  2013-10       Impact factor: 2.983

2.  Patterns of Antipsychotic Prescribing by Physicians to Young Children.

Authors:  Haiden A Huskamp; Marcela Horvitz-Lennon; Ernst R Berndt; Sharon-Lise T Normand; Julie M Donohue
Journal:  Psychiatr Serv       Date:  2016-07-15       Impact factor: 3.084

3.  Stepped care versus standard cognitive-behavioral therapy for obsessive-compulsive disorder: a preliminary study of efficacy and costs.

Authors:  David F Tolin; Gretchen J Diefenbach; Christina M Gilliam
Journal:  Depress Anxiety       Date:  2011-03-04       Impact factor: 6.505

4.  The Cost of Illness Associated with Stepped Care for Obsessive-Compulsive Disorder.

Authors:  Gretchen J Diefenbach; David F Tolin
Journal:  J Obsessive Compuls Relat Disord       Date:  2012-12-27       Impact factor: 1.677

5.  The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder.

Authors:  Alix Arnaud; Ellison Suthoff; Rita M Tavares; Xuan Zhang; Aditi J Ravindranath
Journal:  Pharmacoeconomics       Date:  2021-04-28       Impact factor: 4.981

6.  Employer-Led Strategies to Improve the Value of Health Spending: A Systematic Review.

Authors:  Richard M Weinmeyer; Megan McHugh; Emma Coates; Sarah Bassett; Linda C O'Dwyer
Journal:  J Occup Environ Med       Date:  2022-03-01       Impact factor: 2.306

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.